Hong Kong Pharma Digital Technology Holdings Ltd
HKPD$9M
Micro CapNASDAQWholesale-Drugs, Proprietaries & Druggists' Sundries🇺🇸North AmericaKOWLOON27 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
HKPD News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
EI-001
Non-segmental Vitiligo
INS018_055
Idiopathic Pulmonary Fibrosis (IPF)
EI-1071 tablet, oral
Mild, Moderate, or Severe Alzheimer's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EI-001 | Phase 2 | Non-segmental Vitiligo | - | - |
INS018_055 | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) | - | - |
EI-1071 tablet, oral | Phase 2 | Mild, Moderate, or Severe Alzheimer's Disease | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply